Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... density cholesterol (LDC) by 52.4% (p<0.001) was found after 24 weeks in Group 1. Achieving the target LDC ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... to atorvastatin and at the same time the rosuvastatin group  was safer regarding liver enzymes elevation, p<0.001 ..."
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... , respectively (p<0.001). Episodes of sinus tachycardia decreased on 52.3% (p<0.001) and 48,5% (p<0.01 ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... antiarrhythmic therapy) and second group (basic antiarrhythmic therapy and atorvastatin (Liptonorm, Pharmstandart ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... ), respectively. LDC levels decreased from 4.4±0.7 to 2.4±0.4 mmol/l (p<0.001) and from 4.2±0.7 to 2.2±0.6 mmol/l ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... of atorvastatin is demonstrated in according to comparative studies. Results of clinical studies on atorvastatin ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... application led to significant reduction in levels of TC (from 247.1±27 to 186.5±12 mg/dl; p<0.001), LDC (from ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... Aim. To study the antihypertensive and hypolipidemic effect of a group of drugs including ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... with atorvastatin (59 patients, 81% males, mean age 62.1±7.5 years); patients of group 2 received no HMG-CoA ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... atorvastatin 40 mg per day. Blood LDC levels were examined only in 5% of patients during statins therapy ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... .8±8.4 and -30.4±12.8/18.7±8 mm Hg for groups 1 and 2, respectively , p<0.001 for the both groups ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... prescribed group of lipid-lowering drugs was statins, while combined treatment or monotherapy with other ..."
 
Vol 12, No 3 (2016) ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS Abstract  PDF (Eng)  similar documents
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov
"... correlated with age: At (p=0.004); Et/At (p=0.001); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... .3%, "probable" – 18.1%. Patients with definite FH diagnosis showed higher level of TCh (p<0.001), LDL ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... group were older than these in the first group (p<0.001). Patients of the group 1 compared to the group ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... (p<0.001), they were more often diagnosed with left ventricular aneurysm (p=0.001), chronic kidney ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... size of these groups. Achievement of target LDC level was observed more often in use of statins ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... relative wall thickness (p=0,021) and LV ejection fraction (p<0,001). Patients of this group were ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... %) and 2nd groups (46%) was detected as compared with the control group (p<0.001). Standard deviation ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... valve in patients of groups 1 and 2 was lower than in the control by 15% and 17%, respectively (p<0.001 ..."
 
Vol 9, No 4 (2013) EFFECT OF IRON AND SELENIUM DRUGS ON DIASTOLIC MYOCARDIAL FUNCTION IN PATIENTS WITH ANEMIC CARDIOMYOPATHY Abstract  similar documents
E. V. Goncharova, A. V. Govorin
"... with cardiomyopathy. Flow rate rapid filling re- duced by 27.1% compared with this in control (p<0.001), and flow rate ..."
 
Vol 16, No 2 (2020) Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries Abstract  similar documents
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
"... with myocardial infarction (MI) according to RECORD-3 are more often male smokers (p=0.001) with a heredity ..."
 
Vol 6, No 4 (2010) COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov
"... after 12 weeks of therapy in the 1st group and from 96.9±4.9 to 66.3±5.6 bt/min (р<0.001) in the 2nd ..."
 
Vol 11, No 3 (2015) THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION Abstract  similar documents
I. L. Tepoyan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safaryan, V. A. Vygodin, V. E. Novikov, L. M. Murashko
"... in atenolol group this index decreased from -1.5±0.7 SD to -1.6±0.64 SD (p<0.001). When evaluating T-test ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... depending on the level of lipid metabolism: group I (n=33) received atorvastatin (10-40 mg/day), and control ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... - 0.9 [0.8;1.31 ], in the 2nd group - 0.8 [0.78; 1.2] with a control value of 1.6 [1.2;1.94] (p<0.001 ..."
 
Vol 15, No 6 (2019) Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) Abstract  similar documents
D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash
"... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.001), as well as the course ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... The results of the recently completed clinical studies on the efficacy of atorvastatin in high ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... (from 9.3±0.5 to 8.4±0.4 mm Hg; p<0.001) at night. Patients in the amlodipine/lisinopril group compared ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
 
Vol 15, No 5 (2019) Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) Abstract  similar documents
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... a hypercholesterolemia – 47% and 59.7% (p<0.001). The incidence of drug administration with proved positive prognostic ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... .05). Group 4: the average CHF class decreased by 41.4% (p<0.001), EF increased by 32.8% (p<0.001). Conclusion ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... (compensated) of LV remodeling increased by 18% (p<0.001) in group A2, and by 6%, (p=0.03) in group A1. After ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... and more often had excess body weight (p<0.001). The majority of current smokers were males (p<0.001 ..."
 
Vol 7, No 4 (2011) GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev
"... (IHD), and treatment compliance within 6 months of observation in group of men and group of women after ..."
 
Vol 13, No 3 (2017) ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... with the control-group (p<0.001). The revealed abnormalities especially increased in patients with PH, they also ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... .14 vs 1.27 in the control group (p<0.001). In the main group, adherence to antihypertensive therapy ..."
 
Vol 15, No 1 (2019) Prognostic Value of ECG in Patients with Pulmonary Embolism Abstract  similar documents
I. S. Mullova, T. V. Pavlova, S. M. Khokhlunov, D. V. Duplyakov
"... -complete right bundle branch block (RBBB) (16.3 vs 37.9%; p=0.001), ST segment elevation in lead III (9 ..."
 
Vol 9, No 6 (2013) EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
T. V. Pinchuk, Y. N. Fedulaev, G. A. Khairetdinova, A. A. Kozina, V. N. Ryzhenkov, N. M. Ahmedzhanov
"... ventricular filling velocity at atrial contraction) ratio by 18.7% (p<0.001) was found in the main group ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... systolic and diastolic blood pressure (SBP, DBP) reduced in both groups р<0,0001. There were ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... , in the control group (p<0,001). The number of hospital admissions decreased in 4.8 times in men (p<0.0001) and 12 ..."
 
Vol 7, No 6 (2011) MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya
"... associations of MAC presence with symptomatic atherosclerotic peripheral arterial disease (p <0.001; ß=0 ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... with the control group women had higher values of minimum (52.3±0.4 vs 47.5±0.4; p<0.001) and mean (78.5±0.5 vs 75 ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... ) and LDL cholesterol reduced on 25,2% and 33,6% (p<0,001), respectively. Next 6 weeks of therapy ..."
 
Vol 7, No 6 (2011) DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL Abstract  similar documents
E. I. Tarlovskaya, D. A. Suvorova, A. A. Sobolev
"... =0.826; p=0.0001), HT duration (r=0.498; p=0.0001), BPs level (r=0.466; p=0.001), microalbuminuria ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... .1 min-1) than in group 2 (74,5±8,2 and 73,9±7,0 min-1, respectively, p<0,001 for both periods ..."
 
Vol 1, No 3 (2005) COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS Abstract  similar documents
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin
"... ) and diastolic BP – by 17,5% (р<0,001). 76% and 70% of patients in NF and CA groups, respectively, reached target ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..."
 
Vol 8, No 5 (2012) ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE Abstract  similar documents
M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
"... ), as well as daily and night BP variability (p=0.001) was also found in patients of group 2 compared ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... to the first and to control groups. In the second group LF increased from 223.8±56.2 to 734±90.9 мs2 (p<0.001 ..."
 
Vol 8, No 2 (2012) SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS Abstract  similar documents
I. S. Dzherieva, N. I. Volkova, S. I. Rapoport
"... .3%, respectively; p<0.001) and glucose metabolism disorders rates (19.0 vs. 10.6%, respectively; p<0.001) were also ..."
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... (38.5% vs 20.6%, p<0.001), fewer patients to whom the FIS was applied (33.3% vs 45.7%; p=0 ..."
 
Vol 14, No 1 (2018) EVALUATION OF LEPTIN SERUM LEVELS IN PATIENTS WITH METABOLIC SYNDROME AND LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY Abstract  PDF (Eng)  similar documents
O. M. Drapkina, R. N. Shepel, T. A. Deeva
"... to the group without MS (17.64±16.87 ng/ml), p<0.001. At that women had significantly higher levels of serum ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..."
 
Vol 5, No 1 (2009) EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina
"... ,1 mm Hg (p<0,001) and with morning taking – to 131,8±1,6/79,2±1,1 mm Hg (p<0,001). Evening ramipril ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... % (p<0.001) in the main group. Decrease in total cholesterol (TC) by -3.6% (p<0.05) and increase ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... (LVMI) in patients in Group 1 was 134.0±6,5g/m² vs 98.4±3.3 g/m² in Group 2 (p<0.001). LVMI in men ..."
 
Vol 9, No 4 (2013) URAPIDIL: MODERN MEDICINE FOR THE TREATMENT OF HYPERTENSIVE CRISES Abstract  similar documents
A. V. Melekhov, Yu. I. Ostrovskaya
"... and 220 minutes, respectively, (p<0.001 for both), and diastolic BP from 108 (102-119) mm Hg to 90 (82-97 ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... noticeable in women up to 50 years old (T allele – OR 0,21; C allele – OR 4,57, p=0,001). Conclusion ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... and 11 mm Hg respectively. Angina attacks were registered less often in patients of carvedilol group (р=0,001 ..."
 
Vol 15, No 1 (2019) Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination Abstract  similar documents
O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec
"... (from 7.3±2.5 to 9.5±2.9 words; p<0.001). In control group at the end of follow-up compared to baseline ..."
 
Vol 14, No 3 (2018) FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin
"... ; Tei index increased in patients with ascites compared with the control group and the 1st group, p<0.001 ..."
 
Vol 12, No 2 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 Abstract  PDF (Eng)  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... plaques: r=0.46 (р<0.001) in the younger group and r=0.47 (р<0.001) in the older one. We didn’t find any ..."
 
Vol 12, No 3 (2016) THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY Abstract  PDF (Eng)  similar documents
T. Y. Gromyko, S. A. Sayganov
"... was a significant predictor of sinus rhythm preservation (р<0.001) and reduction in a number of AF paroxysms р<0.001 ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... .3 mmol/L and 2.3 mmol/L, respectively (p<0.001). Deterioration in the dynamics of alanine ..."
 
Vol 13, No 2 (2017) POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER Abstract  similar documents
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
"... ) and persisted until the 6th month (74.2±14.9 beats/min, p<0.001). In the main group, the frequency of complaints ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... significantly in the 1st group in comparison with the 2nd group (29,5 % vs 11,5 %, p <0,001). The exercise ..."
 
Vol 4, No 4 (2008) INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova
"... was observed 5,4 times more often in women than this in men (18,5% and 3,4%, respectively, р<0,001 ..."
 
Vol 4, No 2 (2008) MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY Abstract  similar documents
L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak
"... than this in control group (p<0,01) during RH test. After mildronate infusion increase in %∆D during RH ..."
 
Vol 14, No 4 (2018) Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis Abstract  similar documents
M V. Chistyakova, A. V. Govorin, N. N. Kushnarenko
"... were identified in patients with VLC with ascites, p<0.001. In the study of LV remodeling, concentric ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... and hypertriglyceridemia was similar in the compared groups of patients with MS regardless of the presence of gout (p<0.001 ..."
 
Vol 11, No 6 (2015) RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) Abstract  similar documents
D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin
"... coronary artery lesions in both PPCI and PIS subgroups (p<0.001). This has determined more frequent ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... lower in the group of vaccinated patients: by 36% (p=0.001) and by 59% (p=0.008), respectively ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
"... Hg in group 2 (p<0.001 for both groups), intergroup differences were insignificant. Target BP levels ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... of group C and 95,5% of group M reached target levels of BP. Significant reduction of glucose (p<0,01 ..."
 
Vol 16, No 2 (2020) Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG Abstract  similar documents
O. V. Fedorishina, K. V. Protasov, A. M. Torunova
"... .2 (80;92) to 125.1 (118;134)/74.0 (70;81) mm Hg, respectively, in the 2nd group (p<0.001 for all changes ..."
 
Vol 13, No 6 (2017) RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT Abstract  similar documents
A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev
"... in 44.8% of hypertensive patients vs 22.4% in people without HT (p<0.001). The people with HT ..."
 
Vol 14, No 2 (2018) SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING Abstract  similar documents
E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina
"... ), percentage of SBP and DBP levels decrease during CAS (γ=0.404; p<0.01 and γ=0.458; p<0.001, respectively ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... to valsartan therapy demonstrated a significant increase in 24 h cGMP urinary excretion-on Day 1 (95%, p<0.001 ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... and randomly split in two groups. Patients of the first group (n=160) received carvedilol as a basic therapy ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... in the blood plasma 5.42 (5.26–5.76) vs 4.88 (4.86–4.94) hours, respectively; p<0.001. Original enalapril ..."
 
Vol 12, No 1 (2016) Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease Abstract  PDF (Eng)  similar documents
E. I. Leonova, G. G. Shechyan, V. S. Zadionchenko, T. V. Adasheva, A. D. Deev, I. V. Fedorova
"... .356; p=0.011), CRP level (R=0.442; p=0.001), the sizes of both atria (p<0.001), isovolumic relaxation ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... myocardial mass (from 170 [225.5;213.5] to 159 [146;167] g; p<0.001), and size of the left atrium (LA; from ..."
 
Vol 7, No 5 (2011) ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS Abstract  similar documents
G. P. Arutyunov, L. G. Oganezova
"... was higher than this in enalaprilat group (96.7 vs 73.3%; p<0.001), for the first hour systolic BP (SBP ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0 ..."
 
Vol 12, No 4 (2016) Renal filtration function in patients with gout Abstract  similar documents
N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko
"... ) was revealed in 72.4% of male patients, with the prevalence in patients with HT (76.6 vs 61%; p<0.001 ..."
 
1 - 100 of 617 Items 1 2 3 4 5 6 7 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)